alltrials
InterMune drops EMA lawsuit over data release
June 10, 2014Research and Development, Sales and Marketing EMA, EU, Esbriet, Goldacre, InterMune, alltrials, lung
InterMune has ended a year-long legal spat with the European Medicines Agency over the potential release of data for its …
Lilly the latest to open up data
June 4, 2014Medical Communications, Research and Development, Sales and Marketing Goldacre, NHS, alltrials, data, lilly, transparency, trials
Eli Lilly is to begin sharing its clinical trial data with scientific researchers through a website housing information from several …
BMJ slams EMA ‘U-turn’
May 30, 2014Medical Communications, Research and Development, Sales and Marketing BMJ, EMA, alltrials, data, transparency
The BMJ has attacked the European Medicines Agency for what it believes is a decision to ‘backtrack’ on public access …
Clinical trials transparency: the journey so far
May 12, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, NHS, alltrials, rawal, transparency
There has been considerable publicity over the last year or two about transparency of information in clinical trials. However, activity …
Tamiflu stockpiling ‘unjustifiable’ and wasted £424m
April 10, 2014Medical Communications, Research and Development, Sales and Marketing BMJ, Cochrane, Tamiflu, alltrials
Governments around the world may have squandered hundreds of millions of pounds on stockpiling Tamiflu, according to a review by …
Boehringer: ‘devil in detail’ on new drug pricing policy
April 10, 2014Medical Communications, Sales and Marketing Boehringer, PPRS, VBP, Zinta Krumins, alltrials, vba
Zinta Krumins, the newly-appointed managing director of Boehringer Ingelheim UK and Ireland, has warned that the ‘devil is in the …
EMA transparency agenda sees more delay
April 9, 2014Medical Communications, Sales and Marketing AbbVie, EFPIA, EMA, Europe, InterMune, alltrials, parliament, transparency
The European Medicines Agency is to further delay its policy over clinical trial transparency, saying it needs more time to …
AbbVie drops EMA legal case after compromise
April 4, 2014Medical Communications, Research and Development, Sales and Marketing AbbVie, Abbott, EMA, alltrials
AbbVie will no longer seek to stop the European Medicines Agency from releasing data on its blockbuster arthritis treatment Humira. …
EU votes for trial transparency
April 3, 2014Research and Development, Sales and Marketing ABPI, EFPIA, EU, Goldacre, UK, alltrials, transparency, willmott
Europe took a decisive step toward forcing pharma to open up its clinical trial data last night, after the EU …
Data transparency debate: Europe decides its future
March 24, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EFPIA, EMA, EU, Goldacre, NHS, alltrials, european, transparency
Transparency became a major issue in 2013 as various new pressure groups sprung up with the shared aim of forcing …
Clinical studies still not being published
March 4, 2014Research and Development, Sales and Marketing ABPI, EMA, alltrials, clinical trials, csr
Half of all trials registered on a US clinical study database are not being published in public journals. This is …
Novartis extends trial transparency
February 27, 2014Medical Communications, Research and Development, Sales and Marketing EFPIA, EMA, Goldacre, Novartis, alltrials, transparency
Novartis has become the latest pharmaceutical company to allow greater scrutiny of its clinical trial data.
J&J reveals more on transparency policy
February 3, 2014Medical Communications, Research and Development, Sales and Marketing Goldacre, J&J, JJ, alltrials, johnson, transparency, yoda
Johnson & Johnson’s pharma subsidiary Janssen has given Pharmafile more details on its new transparency policy, which will see both …
GSK and Sanofi expand transparency
January 6, 2014Research and Development, Sales and Marketing GSK, Goldacre, Sanofi, alltrials, transparency
GlaxoSmithKline and Sanofi have announced separate moves which will shine greater light on both companies’ clinical trial data. GSK has …
Europe to vote on greater trial transparency
December 17, 2013Research and Development, Sales and Marketing EU, Europe, Goldacre, alltrials, transparency
Pharma companies and academic researchers will be obliged to upload the results of all their European clinical trials to a …
Latest content
